No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025
Maxim Group Remains a Hold on Processa Pharmaceuticals (PCSA)
Processa Pharmaceuticals | 10-K: FY2024 Annual Report
Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently
Express News | Processa Pharmaceuticals Inc - on Feb 4, Received Nasdaq Notice for Bid Price Non-Compliance
Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference